Skip to content

Meet our Team

We are a team of innovators, scientists, and physicians, collectively driven to create therapies that change lives.

Collaboration
is at our core

We are committed to partnering
with the SCI Community to
restore movement, function,
and independence

Our story

Watch video

Connect with our Team

Leadership

    Join us

    We are always looking for talented, mission-driven individuals in Europe and the US to help us create technologies and therapies that make a difference.

    Show me open roles

    Learn about our Sustainability Initiatives

    Summary

    Sustainability is integral to the way we do business. The principles that guide us are highlighted in our ONWARD Medical Code and intertwined in how we operate.

    Learn more about our Sustainability initiatives

    Support our Community Partners

    .NeuroRestore

    Christopher & Dana Reeve Foundation

    Spinal Research

    Wings for Life

    Fördergemeinschaft der Querschnittgelähmten (FGQ)

    Praxis

    North American Spinal Cord Injury Consortium

    To register for email alerts,
    sign up on our Contact page

    Fill out the form
    The ONWARD® Medical ARCEX® System is FDA cleared for use in the United States and CE marked in accordance with EU Medical Device Regulation 2017/745. ONWARD ARCIM® and ARCBCI™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

    Indication for Use (US): The ARCEX® System is intended to deliver programmed transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic and with take-home exercises in the home to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive). The ARC-EX System is intended to be operated in medical centers by Rehabilitation Professionals and at home by Patients and Persons Providing Assistance to the Patient as needed.

    Indication for Use (EU): The ARCEX® System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic and with take-home exercises in the home to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).